
TRXPF
Healthcare · Drug Manufacturers - Specialty & Generic · $699.5M market cap
Latest report
After the close
The next earnings date isn’t on the calendar yet.
Analyst consensus
Analyst estimates aren’t available for this symbol.
Beat estimates in 0 of the last 4 reported quarters.
EPS surprise versus the estimate at the time of the report.
| Date | Session | Estimate | Actual | Surprise |
|---|---|---|---|---|
| Feb 9, 2023 | After the close | — | 0.27 | — |
| Oct 30, 2022 | After the close | — | 0.26 | — |
| Jul 28, 2022 | After the close | — | 0.26 | — |
| Apr 27, 2022 | After the close | — | 0.27 | — |
| Feb 9, 2022 | After the close | — | 0.36 | — |
| Oct 28, 2021 | After the close | — | 0.32 | — |
| Jul 29, 2021 | After the close | 0.00 | 0.32 | — |
| Apr 27, 2021 | After the close | 0.00 | 0.26 | — |
| Feb 3, 2021 | After the close | 0.00 | 0.14 | — |
| Oct 29, 2020 | After the close | — | 0.24 | — |
| Jul 30, 2020 | After the close | — | 0.24 | — |
| Apr 29, 2020 | After the close | — | 0.31 | — |
| Feb 5, 2020 | After the close | — | 0.29 | — |
| Oct 30, 2019 |
Torii Pharmaceutical Co., Ltd. manufactures and markets pharmaceutical products in Japan. It offers therapeutic agents, such as Riona for the treatment of hyperphosphatemia; and REMITCH, an oral therapeutic agent used for the treatment of pruritus in dialysis and liver disease patients. The company also provides ANTEBATE that is used for the treatment of skin diseases, such as atopic dermatitis and contact…
| After the close |
| — |
| 0.30 |
| — |
| Jul 30, 2019 | After the close | — | 0.09 | — |
| Apr 24, 2019 | After the close | — | -0.77 | — |
| Feb 5, 2019 | After the close | — | 9.17 | — |
| Oct 30, 2018 | After the close | — | -0.35 | — |
| Jul 29, 2018 | After the close | — | 0.22 | — |
| Apr 25, 2018 | After the close | — | 0.32 | — |
| Feb 5, 2018 | After the close | — | 0.19 | — |